NICE approval of SIRT
Wednesday, August 03, 2011
The National Institute for Health and
Clinical Excellence (NICE) has announced that it has produced
guidance to support the routine use of SIRT (Selective Internal
Radiation Therapy)for the treatment of patients with liver tumours
resulting from bowel cancer.
This welcome decision culminates an extensive dialogue between
patients, patient groups, clinical experts and
parliamentarians.
SIRT is used for the treatment of inoperable liver tumours and
involves injecting millions of tiny radioactive microspheres into
the liver via the hepatic artery.